Skip to main content

Robert (“Bob”) W. Azelby

Equibles does not estimate personal net worth.

Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.

Get AUTL alerts

About Robert (“Bob”) W. Azelby

Robert (“Bob”) W. Azelby is recorded as Board Member at Autolus Therapeutics plc (AUTL) since January 9, 2024. Autolus Therapeutics plc reported in an 8-K filed January 10, 2024 that Robert (“Bob”) W. Azelby was appointed Class II director, effective January 9, 2024. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 3 others.

“the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Robert (“Bob”) W. Azelby to serve as a Class II director of the Company, effective January 9, 2024.”
Autolus Therapeutics plc Form 8-K, filed January 10, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Autolus Therapeutics plc

Recent activity